194 related articles for article (PubMed ID: 33509939)
1. The CDCP1 Signaling Hub: A Target for Cancer Detection and Therapeutic Intervention.
Khan T; Kryza T; Lyons NJ; He Y; Hooper JD
Cancer Res; 2021 May; 81(9):2259-2269. PubMed ID: 33509939
[TBL] [Abstract][Full Text] [Related]
2. CDCP1: A promising diagnostic biomarker and therapeutic target for human cancer.
Qi X; Gao J; Li Z; Zhang G; Li J; Fu Y; Cai M; Wang H; Tong T
Life Sci; 2022 Jul; 301():120600. PubMed ID: 35504333
[TBL] [Abstract][Full Text] [Related]
3. Effective targeting of intact and proteolysed CDCP1 for imaging and treatment of pancreatic ductal adenocarcinoma.
Kryza T; Khan T; Puttick S; Li C; Sokolowski KA; Tse BW; Cuda T; Lyons N; Gough M; Yin J; Parkin A; Deryugina EI; Quigley JP; Law RHP; Whisstock JC; Riddell AD; Barbour AP; Wyld DK; Thomas PA; Rose S; Snell CE; Pajic M; He Y; Hooper JD
Theranostics; 2020; 10(9):4116-4133. PubMed ID: 32226543
[No Abstract] [Full Text] [Related]
4. The cell surface glycoprotein CUB domain-containing protein 1 (CDCP1) contributes to epidermal growth factor receptor-mediated cell migration.
Dong Y; He Y; de Boer L; Stack MS; Lumley JW; Clements JA; Hooper JD
J Biol Chem; 2012 Mar; 287(13):9792-9803. PubMed ID: 22315226
[TBL] [Abstract][Full Text] [Related]
5. Substrate-biased activity-based probes identify proteases that cleave receptor CDCP1.
Kryza T; Khan T; Lovell S; Harrington BS; Yin J; Porazinski S; Pajic M; Koistinen H; Rantala JK; Dreyer T; Magdolen V; Reuning U; He Y; Tate EW; Hooper JD
Nat Chem Biol; 2021 Jul; 17(7):776-783. PubMed ID: 33859413
[TBL] [Abstract][Full Text] [Related]
6. Suppression of autophagy by CUB domain-containing protein 1 signaling is essential for anchorage-independent survival of lung cancer cells.
Uekita T; Fujii S; Miyazawa Y; Hashiguchi A; Abe H; Sakamoto M; Sakai R
Cancer Sci; 2013 Jul; 104(7):865-70. PubMed ID: 23510015
[TBL] [Abstract][Full Text] [Related]
7. CUB domain-containing protein 1 (CDCP1) binds transforming growth factor beta family members and increase TGF-β1 signaling pathway.
Predes D; Cruz JVR; Abreu JG; Mendes FA
Exp Cell Res; 2019 Oct; 383(1):111499. PubMed ID: 31302030
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic Ras/ERK signaling activates CDCP1 to promote tumor invasion and metastasis.
Uekita T; Fujii S; Miyazawa Y; Iwakawa R; Narisawa-Saito M; Nakashima K; Tsuta K; Tsuda H; Kiyono T; Yokota J; Sakai R
Mol Cancer Res; 2014 Oct; 12(10):1449-59. PubMed ID: 24939643
[TBL] [Abstract][Full Text] [Related]
9. Blocking of CDCP1 cleavage in vivo prevents Akt-dependent survival and inhibits metastatic colonization through PARP1-mediated apoptosis of cancer cells.
Casar B; He Y; Iconomou M; Hooper JD; Quigley JP; Deryugina EI
Oncogene; 2012 Aug; 31(35):3924-38. PubMed ID: 22179830
[TBL] [Abstract][Full Text] [Related]
10. Roles of CUB domain-containing protein 1 signaling in cancer invasion and metastasis.
Uekita T; Sakai R
Cancer Sci; 2011 Nov; 102(11):1943-8. PubMed ID: 21812858
[TBL] [Abstract][Full Text] [Related]
11. Src Kinase Is Biphosphorylated at Y416/Y527 and Activates the CUB-Domain Containing Protein 1/Protein Kinase C δ Pathway in a Subset of Triple-Negative Breast Cancers.
Nelson LJ; Wright HJ; Dinh NB; Nguyen KD; Razorenova OV; Heinemann FS
Am J Pathol; 2020 Feb; 190(2):484-502. PubMed ID: 31843498
[TBL] [Abstract][Full Text] [Related]
12. CUB domain-containing protein 1, a prognostic factor for human pancreatic cancers, promotes cell migration and extracellular matrix degradation.
Miyazawa Y; Uekita T; Hiraoka N; Fujii S; Kosuge T; Kanai Y; Nojima Y; Sakai R
Cancer Res; 2010 Jun; 70(12):5136-46. PubMed ID: 20501830
[TBL] [Abstract][Full Text] [Related]
13. Antibody mediated CDCP1 degradation as mode of action for cancer targeted therapy.
Kollmorgen G; Niederfellner G; Lifke A; Spohn GJ; Rieder N; Harring SV; Bauss F; Burtscher H; Lammers R; Bossenmaier B
Mol Oncol; 2013 Dec; 7(6):1142-51. PubMed ID: 24055141
[TBL] [Abstract][Full Text] [Related]
14. Elevated CDCP1 predicts poor patient outcome and mediates ovarian clear cell carcinoma by promoting tumor spheroid formation, cell migration and chemoresistance.
He Y; Wu AC; Harrington BS; Davies CM; Wallace SJ; Adams MN; Palmer JS; Roche DK; Hollier BG; Westbrook TF; Hamidi H; Konecny GE; Winterhoff B; Chetty NP; Crandon AJ; Oliveira NB; Shannon CM; Tinker AV; Gilks CB; Coward JI; Lumley JW; Perrin LC; Armes JE; Hooper JD
Oncogene; 2016 Jan; 35(4):468-78. PubMed ID: 25893298
[TBL] [Abstract][Full Text] [Related]
15. CDCP1 promotes compensatory renal growth by integrating Src and Met signaling.
Kajiwara K; Yamano S; Aoki K; Okuzaki D; Matsumoto K; Okada M
Life Sci Alliance; 2021 Apr; 4(4):. PubMed ID: 33574034
[TBL] [Abstract][Full Text] [Related]
16. Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer.
Harrington BS; He Y; Davies CM; Wallace SJ; Adams MN; Beaven EA; Roche DK; Kennedy C; Chetty NP; Crandon AJ; Flatley C; Oliveira NB; Shannon CM; deFazio A; Tinker AV; Gilks CB; Gabrielli B; Brennan DJ; Coward JI; Armes JE; Perrin LC; Hooper JD
Br J Cancer; 2016 Feb; 114(4):417-26. PubMed ID: 26882065
[TBL] [Abstract][Full Text] [Related]
17. FBXL14 abolishes breast cancer progression by targeting CDCP1 for proteasomal degradation.
Cui YH; Kim H; Lee M; Yi JM; Kim RK; Uddin N; Yoo KC; Kang JH; Choi MY; Cha HJ; Kwon OS; Bae IH; Kim MJ; Kaushik N; Lee SJ
Oncogene; 2018 Oct; 37(43):5794-5809. PubMed ID: 29973690
[TBL] [Abstract][Full Text] [Related]
18. Regulation of inside-out β1-integrin activation by CDCP1.
Pollan SG; Huang F; Sperger JM; Lang JM; Morrissey C; Cress AE; Chu CY; Bhowmick NA; You S; Freeman MR; Spassov DS; Moasser MM; Carter WG; Satapathy SR; Shah K; Knudsen BS
Oncogene; 2018 May; 37(21):2817-2836. PubMed ID: 29511352
[TBL] [Abstract][Full Text] [Related]
19. Theranostic Targeting of CUB Domain Containing Protein 1 (CDCP1) in Pancreatic Cancer-Letter.
Birnbaum DJ; Finetti P; Birnbaum D; Bertucci F
Clin Cancer Res; 2020 Oct; 26(20):5539. PubMed ID: 33060289
[No Abstract] [Full Text] [Related]
20. Inhibition of tumor metastasis: functional immune modulation of the CUB domain containing protein 1.
Fukuchi K; Steiniger SC; Deryugina E; Liu Y; Lowery CA; Gloeckner C; Zhou B; Kaufmann GF; Quigley JP; Janda KD
Mol Pharm; 2010 Feb; 7(1):245-53. PubMed ID: 19916495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
